{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:03:39Z","timestamp":1784070219463,"version":"3.55.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T00:00:00Z","timestamp":1721865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001863","name":"New Energy and Industrial Technology Development Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011907","name":"Mishima Kaiun Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011907","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.heliyon.2024.e35232","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T20:42:38Z","timestamp":1722026558000},"page":"e35232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Anti-angiogenic activity of a novel angiostatin-like plasminogen fragment produced by a bacterial metalloproteinase"],"prefix":"10.1016","volume":"10","author":[{"given":"Kosuke","family":"Shimizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taolin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3340-7312","authenticated-orcid":false,"given":"Keiji","family":"Hasumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2024.e35232_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0092-8674(94)90200-3","article-title":"Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma","volume":"79","author":"O'Reilly","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e35232_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nm0696-689","article-title":"Angiostatin induces and sustains dormancy of human primary tumors in mice","volume":"2","author":"O'Reilly","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.heliyon.2024.e35232_bib3","doi-asserted-by":"crossref","first-page":"29568","DOI":"10.1074\/jbc.274.41.29568","article-title":"Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance","volume":"274","author":"O'Reilly","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib4","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.4049\/jimmunol.161.12.6845","article-title":"Matrix metalloproteinases generate angiostatin: effects on neovascularization","volume":"161","author":"Cornelius","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.heliyon.2024.e35232_bib5","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/hep.510280413","article-title":"Expression of human macrophage metalloelastase gene in hepatocellular carcinoma: correlation with angiostatin generation and its clinical significance","volume":"28","author":"Gorrin Rivas","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.heliyon.2024.e35232_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0092-8674(00)81926-1","article-title":"Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma","volume":"88","author":"Dong","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2024.e35232_bib7","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.bjc.6692167","article-title":"Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen","volume":"81","author":"Heidtmann","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e35232_bib8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1515\/BC.2004.061","article-title":"Human kallikrein 6 activity is regulated via an autoproteolytic mechanism of activation\/inactivation","volume":"385","author":"Bay\u00e9s","year":"2004","journal-title":"Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib9","doi-asserted-by":"crossref","first-page":"10868","DOI":"10.1073\/pnas.94.20.10868","article-title":"The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin","volume":"94","author":"Gately","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35232_bib10","doi-asserted-by":"crossref","first-page":"20641","DOI":"10.1074\/jbc.272.33.20641","article-title":"Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells","volume":"272","author":"Stathakis","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1432-1033.2004.03985.x","article-title":"Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity","volume":"271","author":"Ohyama","year":"2004","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib12","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1073\/pnas.96.6.2811","article-title":"Angiostatin binds ATP synthase on the surface of human endothelial cells","volume":"96","author":"Moser","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35232_bib13","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1083\/jcb.152.6.1247","article-title":"Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation","volume":"152","author":"Troyanovsky","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.heliyon.2024.e35232_bib14","doi-asserted-by":"crossref","first-page":"39562","DOI":"10.1074\/jbc.M101815200","article-title":"Specific interaction of angiostatin with integrin alpha(v)beta(3) in endothelial cells","volume":"276","author":"Tarui","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1006\/mvre.2002.2444","article-title":"Angiostatin binds to tyrosine kinase substrate annexin II through the lysine-binding domain in endothelial cells","volume":"64","author":"Tuszynski","year":"2002","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.heliyon.2024.e35232_bib16","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1073\/pnas.95.10.5579","article-title":"Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD","volume":"95","author":"Claesson-Welsh","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35232_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.yexcr.2004.09.008","article-title":"Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor","volume":"303","author":"Gonzalez-Gronow","year":"2005","journal-title":"CD26. Exp Cell Res"},{"key":"10.1016\/j.heliyon.2024.e35232_bib18","first-page":"4025","article-title":"Recombinant human angiostatin by twice-daily subcutaneous injection in advanced cancer: a pharmacokinetic and long-term safety study","volume":"9","author":"Beerepoot","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e35232_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/annonc\/mdj055","article-title":"Recombinant human angiostatin (rhAngiostatin) in combination with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer: a phase II study from Indiana University","volume":"17","author":"Kurup","year":"2006","journal-title":"Ann. Oncol."},{"issue":"590","key":"10.1016\/j.heliyon.2024.e35232_bib20","first-page":"592","article-title":"Affinity-capture protease reactor for single-step production and purification of antiangiogenic plasminogen fragment from human plasma","volume":"40","author":"Shimizu","year":"2006","journal-title":"Biotechniques"},{"key":"10.1016\/j.heliyon.2024.e35232_bib21","doi-asserted-by":"crossref","first-page":"14278","DOI":"10.1074\/jbc.M500241200","article-title":"Bacillolysin MA, a novel bacterial metalloproteinase that produces angiostatin-like fragments from plasminogen and activates protease zymogens in the coagulation and fibrinolysis systems","volume":"280","author":"Narasaki","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1355033","article-title":"Overexpression of VEGF\u03b1 as a biomarker of endothelial dysfunction in aortic tissue of \u03b1-GAL-Tg\/KO mice and its upregulation in the serum of patients with Fabry's disease","volume":"11","author":"Lund","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.heliyon.2024.e35232_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/nu13062072","article-title":"Cardiovascular risk and endothelial dysfunction in primary sjogren syndrome is related to the disease activity","volume":"13","author":"\u0141uczak","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e35232_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","article-title":"Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk","volume":"1","author":"Walker","year":"2021","journal-title":"Nat Aging"},{"key":"10.1016\/j.heliyon.2024.e35232_bib25","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s11011-021-00751-2","article-title":"Exercise training ameliorates cognitive dysfunction in amyloid beta-injected rat model: possible mechanisms of Angiostatin\/VEGF signaling","volume":"36","author":"Zarezadehmehrizi","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.heliyon.2024.e35232_bib26","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/all.15637","article-title":"Angiomotin and angiostatin as asthma biomarkers: implications for the regulation of airway remodeling and inflammation","volume":"78","author":"Lee","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.heliyon.2024.e35232_bib27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bbamem.2005.02.003","article-title":"Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels","volume":"1669","author":"Ichikawa","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2024.e35232_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0167-4838(90)90259-I","article-title":"The role of carbohydrate in the function of human plasminogen: comparison of the protein obtained from molecular cloning and expression in Escherichia coli and COS cells","volume":"1039","author":"Gonzalez-Gronow","year":"1990","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.heliyon.2024.e35232_bib29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00320384","article-title":"In vitro characterization of commercial Factor VIII concentrates: long-term follow-up","volume":"49","author":"Miyashita","year":"1984","journal-title":"Blut"},{"key":"10.1016\/j.heliyon.2024.e35232_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1538-7836.2004.00544.x","article-title":"What the structure of angiostatin may tell us about its mechanism of action","volume":"2","author":"Geiger","year":"2004","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e35232_bib31","first-page":"1329","article-title":"A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer","volume":"57","author":"Sim","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e35232_bib32","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1073\/pnas.131067798","article-title":"Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin","volume":"98","author":"Moser","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.heliyon.2024.e35232_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0037-1613016","article-title":"The mechanism of action of angiostatin: can you teach an old dog new tricks?","volume":"87","author":"Moser","year":"2002","journal-title":"Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e35232_bib34","doi-asserted-by":"crossref","first-page":"33564","DOI":"10.1074\/jbc.M205514200","article-title":"Plasmin-induced migration of endothelial cells. A potential target for the anti-angiogenic action of angiostatin","volume":"277","author":"Tarui","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2024.e35232_bib35","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.2174\/138161207782794167","article-title":"The role of annexin II in angiogenesis and tumor progression: a potential therapeutic target","volume":"13","author":"Sharma","year":"2007","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.heliyon.2024.e35232_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fcvm.2018.00108","article-title":"Serum biomarkers of endothelial dysfunction in fabry associated cardiomyopathy","volume":"5","author":"Loso","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.heliyon.2024.e35232_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030619","article-title":"The role of fibrinolytic regulators in vascular dysfunction of systemic sclerosis","volume":"20","author":"Kanno","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.heliyon.2024.e35232_bib38","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1096\/fj.01-0651fje","article-title":"Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation","volume":"16","author":"Benelli","year":"2002","journal-title":"Faseb. J."},{"key":"10.1016\/j.heliyon.2024.e35232_bib39","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1182\/blood-2004-01-0166","article-title":"Angiostatin is a novel anti-inflammatory factor by inhibiting leukocyte recruitment","volume":"105","author":"Chavakis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.heliyon.2024.e35232_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1538-7836.2009.03671.x","article-title":"Human plasminogen kringle 1-5 reduces atherosclerosis and neointima formation in mice by suppressing the inflammatory signaling pathway","volume":"8","author":"Chang","year":"2010","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.heliyon.2024.e35232_bib41","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2174\/1567205011310030004","article-title":"Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer's disease","volume":"10","author":"Ryu","year":"2013","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.heliyon.2024.e35232_bib42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41398-022-01962-6","article-title":"Associations of plasma angiostatin and amyloid-\u03b2 and tau levels in Alzheimer's disease","volume":"12","author":"Cheng","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.heliyon.2024.e35232_bib43","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1158\/1078-0432.CCR-04-1514","article-title":"In vivo generation of angiostatin isoforms by administration of a plasminogen activator and a free sulfhydryl donor: a phase I study of an angiostatic cocktail of tissue plasminogen activator and mesna","volume":"11","author":"Soff","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.heliyon.2024.e35232_bib44","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.7150\/jca.68169","article-title":"Tranexamic acid reduces endometrial cancer effects through the production of angiostatin","volume":"13","author":"Hiramoto","year":"2022","journal-title":"J. Cancer"},{"key":"10.1016\/j.heliyon.2024.e35232_bib45","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jim.2012.06.005","article-title":"Area under the curve as a tool to measure kinetics of tumor growth in experimental animals","volume":"382","author":"Duan","year":"2012","journal-title":"J. Immunol. Methods"}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024112637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024112637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:06:42Z","timestamp":1784066802000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024112637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2405844024112637"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35232","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-angiogenic activity of a novel angiostatin-like plasminogen fragment produced by a bacterial metalloproteinase","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e35232"}}